Haitao An - Maxigen Biotech Director
| 1783 Stock | TWD 42.90 0.30 0.70% |
Director
Haitao An was serving as Director in MAXIGEN BIOTECH INC. since November 6, 2017. An is also General Manager and Director in a Shanghaibased company. since 2017.
| Tenure | 7 years |
| Phone | 886 3 328 7222 |
| Web | https://mbi-bio.com |
Maxigen Biotech Management Efficiency
The company has return on total asset (ROA) of 0.0454 % which means that it generated a profit of $0.0454 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0926 %, meaning that it generated $0.0926 on every $100 dollars invested by stockholders. Maxigen Biotech's management efficiency ratios could be used to measure how well Maxigen Biotech manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Wenhua Chen | Phytohealth Corp | N/A | |
| Jingzhong Cai | Phytohealth Corp | N/A | |
| Kunxian Lin | Yung Zip Chemical | N/A | |
| Deming Lu | Yung Zip Chemical | N/A | |
| Chih Chien | Yung Zip Chemical | N/A | |
| Liren Wu | Phytohealth Corp | N/A | |
| Shangui Lai | Phytohealth Corp | N/A | |
| T Wang | Phytohealth Corp | N/A | |
| Zhiwei Jian | Yung Zip Chemical | N/A | |
| Mingfu Wang | Phytohealth Corp | N/A | |
| Yiling Li | Phytohealth Corp | N/A | |
| Deshan Wang | Phytohealth Corp | N/A | |
| Kun Lin | Yung Zip Chemical | N/A | |
| Jianxin Zheng | Phytohealth Corp | N/A | |
| Qili Li | Yung Zip Chemical | N/A | |
| Shuiyuan Xu | Phytohealth Corp | N/A | |
| Yili Li | Phytohealth Corp | N/A | |
| Yangzong Cai | Yung Zip Chemical | N/A | |
| Guodong Liang | Yung Zip Chemical | N/A | |
| Delang Wu | Phytohealth Corp | N/A | |
| Zisheng Wu | Yung Zip Chemical | N/A | |
Management Performance
| Return On Equity | 0.0926 | |||
| Return On Asset | 0.0454 |
Maxigen Biotech Leadership Team
Elected by the shareholders, the Maxigen Biotech's board of directors comprises two types of representatives: Maxigen Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Maxigen. The board's role is to monitor Maxigen Biotech's management team and ensure that shareholders' interests are well served. Maxigen Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Maxigen Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Haitao An, Director | ||
| Qiyu Chen, Director | ||
| PoHung Lai, Deputy Mang | ||
| WanHow You, Financial Officer | ||
| Lide Xu, Chairman of the Board | ||
| Liyan Zhang, General Manager | ||
| Changbang Zhang, Director | ||
| Xiuyuan Li, Director | ||
| Karen Lee, Sr Admin | ||
| Yamei Huang, Head of Finance | ||
| Zhiqiang Xu, CFO, Head - Finance | ||
| Sitang Deng, Independent Director | ||
| ChingTing Chen, GM Director | ||
| Yijun Huang, Deputy General Manager | ||
| Yihua You, Head of Finance & Accounting | ||
| Zhongqi Chen, Director | ||
| Qixiang Chen, Senior Deputy General Manager | ||
| Liang Zhang, Director | ||
| Shixiong Deng, Independent Director | ||
| Songqing Chen, Deputy General Manager |
Maxigen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Maxigen Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0926 | |||
| Return On Asset | 0.0454 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 3.32 B | |||
| Shares Outstanding | 84.7 M | |||
| Shares Owned By Insiders | 51.89 % | |||
| Shares Owned By Institutions | 2.28 % | |||
| Price To Earning | 33.55 X | |||
| Price To Book | 3.24 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Maxigen Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Maxigen Biotech's short interest history, or implied volatility extrapolated from Maxigen Biotech options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Maxigen Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Maxigen Stock analysis
When running Maxigen Biotech's price analysis, check to measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |